Company Executives

$ Management Team

Mr. Kevin Tang

Chief Executive Officer

Director

Age -

Compensation -

Sex Male

Mr. Michael Hearne

Chief Financial Officer

Age -

Compensation -

Sex Male

Mr. Ryan Cole

Chief Operating Officer

Age -

Compensation -

Sex Male

Mr. Stew Kroll

Chief Development Officer

Age -

Compensation -

Sex Male

Mr. Thomas Wei

Chief Business Officer

Age -

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Mr. Kevin Tang Chief Executive Officer Director	-	-	Male
Mr. Michael Hearne Chief Financial Officer	-	-	Male
Mr. Ryan Cole Chief Operating Officer	-	-	Male
Mr. Stew Kroll Chief Development Officer	-	-	Male
Mr. Thomas Wei Chief Business Officer	-	-	Male

Board of Directors

From the proxy statement filed Apr 24, 2025

Directors

serving now

Independent

7 of 8

stated in the proxy

Average tenure

5.4 years

from year joined

CEO also chairs the board

David L. Hallal

Director	Age	On board	Independent	Committees	Other public boards	2024 pay
Tony Ho	59	2021 4 years	Independent	Nominating and Corporate Governance Committee	Engrail Therapeutics, Inc., Qihan Holdings Limited	$332,764
Robert Iannone	58	2021 4 years	Independent	Compensation and Leadership Development Committee	Autolus Therapeutics plc	$341,264
Ann D. Rhoads	59	2020 5 years	Independent	Compensation and Leadership Development Committee Nominating and Corporate Governance Committee	Repare Therapeutics, Inc., QuidelOrtho Corporation	$345,566
Michel Detheux CEO	58	2012 13 years	Not independent	None stated	None stated	Paid as CEO
David L. Hallal Board chair	58	2018 7 years	Independent	None stated	Scholar Rock Holding Corporation, Seer, Inc., AlloVir, Inc.	$442,822
Tim Van Hauwermeiren	53	2018 7 years	Independent	None stated	Lexeo Therapeutics Inc.	$331,566
Jill DeSimone	69	2024 1 year	Independent	Audit Committee Compensation and Leadership Development Committee	Oncternal Therapeutics, Inc., Praxis Precision Medicines, Inc., Affini-T Therapeutics Inc.	$686,270
David K. Lee	43	2023 2 years	Independent	Audit Committee	None stated	$320,072

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 24, 2025 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$ Management Team

Mr. Kevin Tang

Mr. Michael Hearne

Mr. Ryan Cole

Mr. Stew Kroll

Mr. Thomas Wei

Board of Directors

Related-party transactions

No related-party transactions disclosed